Since the decline of the prices for Diabetes drug from Sanofi from Frankfurt-Höchst to the drug manufacturer builds there. Only a year ago for more than a Hundred jobs in the increasingly digital-dominated Central research and support departments was known. Now, the group from Paris to places: such As the Management of the workforce informed, are to be abolished in Germany until the end of 2020, an additional 800 Points, albeit without the need for redundancies. Germany, in other words at Sanofi in Frankfurt and Berlin. There is a large Marketing and sales unit of the company.

Thorsten Winter

business editor and Internet coordinator of the Rhein-Main-Zeitung.

F. A. Z. Twitter

However, the capital of which comes in the forthcoming removal round apparently largely unscathed. “Marketing and sales in Berlin does not build, there is a rather a question of shifts of staff,” according to the works Council. However, Sanofi in Berlin, I have reduced by 2019 the number of jobs. For the traditional factory in the West of Frankfurt, in the former Hoechst AG had its headquarters, rich in this means nothing Good. “The Frankfurt location will greatly shrink.” The plant has about 7200 Employees.

In November, Sanofi still with the news that around 200 jobs, had a surprise build. This need, the company was unprepared. Because the U.S. food and drug administration FDA had communicated to him, the production and manufacturing of diabetes means just be classified as those of antibodies, as produced by Sanofi at the place in the cell culture system. The result: An increased effort for quality control and quality assurance.

“Germany disproportionately

As it is called in Frankfurt-Höchst is now more affected” will be affected, all parts of the company from the planned job cuts. “In percentage terms, is particularly strong, it hits the research.” They are to be reduced by a fifth. The same applies to support functions such as laboratory jobs (Support). Also in production and manufacturing will be eliminated, therefore, but in percentage terms not many. The speech is of 6.5 percent. To consider

is: Sanofi will lose Most in the foreseeable future, anyway, hundreds of colleagues. The speech is from 600 to 700 employees. Because the group would like to. with the production of chemical drug dealing businesses, including those in Frankfurt, in a new company, bundle and this to the stock exchange to bring active ingredients “After the loss in the year 2019 in the Support functions and the research that is difficult to cope with”, reportedly from the workers ‘ representative.